Cormorant Asset Management’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
2023
Q2
$20.2M Hold
2023
Q1
$21.6M Sell
2022
Q4
$32.1M Sell
2022
Q3
$26.9M Buy
2022
Q2
$10.2M Sell
2022
Q1
$18.5M Buy
2021
Q4
$5.93M Sell
2021
Q3
$5.63M Sell
2021
Q2
$6.27M Sell
2021
Q1
$7.67M Buy
2020
Q4
$1.53M Buy